At a glance
- Originator Bayer Schering Pharma
- Developer Bayer Schering Pharma; Farmades
- Class Antineoplastics; Basic amino acids; Diamino amino acids; Essential amino acids; Uroprotectives
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bladder cancer; Cystitis; Nephritis
Most Recent Events
- 13 Mar 1997 Discontinued-II for Bladder cancer in Germany (Unknown route)
- 13 Mar 1997 Discontinued-II for Bladder cancer in Italy (Unknown route)
- 13 Mar 1997 Discontinued-II for Cystitis in Germany (Unknown route)